Research Article
Diagnostic Value of Dynamic Enhanced Magnetic Resonance Imaging Combined with Serum CA15-3, CYFRA21-1, and TFF1 for Breast Cancer
Table 2
Diagnostic efficacy of different diagnosis modalities.
| | Group | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Accuracy rate (%) |
| | CA15-3 | 60.0 (36/60) | 85.0 (102/120) | 66.7 (36/54) | 81.0 (102/126) | 76.7 (138/180) | | CYFRA21-1 | 56.7 (34/60) | 86.7 (104/120) | 68.0 (34/50) | 80.0 (104/130) | 76.7 (138/180) | | TFF1 | 66.7 (40/60) | 84.2 (101/120) | 67.8 (40/59) | 83.5 (101/121) | 78.3 (141/180) | | MRI | 58.3 (35/60) | 86.7 (104/120) | 68.6 (35/51) | 80.6 (104/129) | 77.2 (139/180) | | Combined examination | 95.0 (57/60) | 83.3 (100/120) | 74.0 (57/77) | 97.1 (100/103) | 87.2 (157/180) |
|
|
